[Integration of new and future biomarkers in the treatment of breast cancer].
In the management of breast cancer patients, there is a need for the development of new and efficient biomarkers to be used for early detection/screening, prognostic evaluation, prediction of therapy sensitivity/resistance and disease monitoring. It is emphasized that before a new biomarker can be implemented in the routine treatment of breast cancer patients, its value must be proven in high-powered, prospective clinical trials. This paper describes each of the above-mentioned indications followed by information on the present status for their development in breast cancer.
Würtz
Sidse Ørnbjerg
SØ
Københavns Universitet, Det Biovidenskabelige Fakultet for Fødevarer, Veterinaermedicin, Frederiksberg C.
Henriksen
Katrine Lütken
KL
Lykkesfeldt
Anne
A
Celis
Julio
J
Brünner
Nils Age
NA
D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor